| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.2 | 0.002 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.8 | 0.002 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.19 | 0.002 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.005 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.17 | 0.006 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.16 | 0.01 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.16 | 0.01 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.02 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.03 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.093 | 0.03 |